Researchers reveal that Maine's Midcoast is the unexpected hotspot for tick-borne diseases like Lyme disease. Discover the reasons behind this alarming trend and how it relates to climate change.
Federal health officials are launching a daring campaign to warn Americans about the dangers of ultra-processed foods, aiming to inspire healthier eating habits and combat chronic diseases like diabetes. With a budget of up to $20 million, the initiative seeks to create viral moments that resonate across social media and beyond.
A new COVID-19 variant known as 'Nimbus' is causing concern due to its painful sore throat symptom, dubbed 'razor blade throat.' While cases rise, experts assure the public that current vaccines should remain effective.
The FDA has approved Gilead's Yeztugo, a twice-yearly injection that could revolutionize HIV prevention, boasting a 99.9% effectiveness. While hailed as a breakthrough, concerns over pricing remain, with activists urging for affordability.
Discover the surprising connection between human actions and the rise of tick-borne diseases. From deforestation to urban sprawl, learn how our choices have created a ticking time bomb for public health.
A new COVID-19 variant, NB.1.8.1, dubbed 'razor blade throat,' is causing severe sore throats in some cases. Experts say it’s more transmissible but not more severe than previous variants.
A new study reveals that living near the coast may increase the risk of serious health issues like diabetes and heart disease due to microplastic pollution. Coastal counties with high plastic levels show alarming disease rates, raising public health concerns.
A new COVID-19 variant known as 'razor blade throat' is causing concern due to painful sore throats. However, experts say it poses a low risk. Learn more about its spread and symptoms.
A new COVID-19 variant nicknamed 'razor blade throat' is causing concern due to its painful sore throat symptom. However, experts say it's not more severe than previous variants. Here's what you need to know.
The U.S. has approved a groundbreaking twice-a-year shot, lenacapvir, for HIV prevention, potentially transforming care. Experts suggest this could significantly reduce new infections.
